Efficacy of Nerve Blocks for Episodic Migraine
NCT05734625
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Episodic Migraine
Interventions
DRUG:
Bupivacaine HCl 0.5% Injectable Solution
DRUG:
Methylprednisolone 40 MG Injection
Sponsor
Mayo Clinic